Hypothyroidism and atherosclerosis

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 6, 2003, Pages 2438-2444

  Cappola, Anne R ^a   Ladenson, Paul W ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROXINE;

ATHEROSCLEROSIS; AUTOPSY; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; DRUG EFFECT; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; META ANALYSIS; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0037631308     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030398     Document Type: Review

References (75)

1. Greenfield WS 1878 Autopsy findings in a 58 year old woman with myxoedema. Published as an appendix to Ord WM Med Chir Trans 61:57
2. Kocher T 1883 Ueber Kropfexstirpation und ihre Eolgen. Arch Klin Chir 29:254-337
3. Vanhaelst L, Neve P, Chailly P, Bastenie PA 1967 Coronary artery disease in hypothyroidism. Observations in clinical myxoedema. Lancet 2:800-802
4. Steinberg AD 1968 Myxedema and coronary artery disease - a comparative autopsy study. Ann Intern Med 68:338-344
5. Gaspar IA 1968 Postmortem observations on the thyroid in atherosclerosis. J Am Geriatr Soc 16:686-695
6. Becker C 1985 Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev 6:432-440
7. Tieche M, Lupi GA, Gutzwiller F, Grob PJ, Studer H, Burgi H 1981 Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease? Br Heart J 46:202-206
8. Mya MM, Aronow WS 2002 Subclinical hypothyroidism is associated with coronary artery disease in older persons. J Gerontol A Biol Sci Med Sci 57: M658-M659
9. Perk M, O'Neill BJ 1997 The effect of thyroid hormone therapy on angiographic coronary artery disease progression. Can J Cardiol 13:273-276
10. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA 1977 Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) 7:495-508
11. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley EJ, Rodgers H, Tunbridge F, Young ET 1996 The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 6:155-160
12. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC 2000 Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132:270-278
13. Ladenson PW, Wilson MC, Gardin J, Kronmal R, Kuller L, Tracy R, Burke G, Fried LP 1994 Relationship of subclinical hypothyroidism to cardiovascular risk factors and disease in an elderly population. Thyroid 4:S-18
14. Staub JJ, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, Burckhardt D, Girard J, Weintraub BD 1992 Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 92:631-642
15. Walton KW, Scott PJ, Dykes PW, Davies JW 1965 The significance of alterations in serum lipids in thyroid dysfunction. II. Alterations of the metabolism and turnover of 131-I-low-density lipoproteins in hypothyroidism and thyrotoxicosis. Clin Sci 29:217-238
16. Chait A, Bierman EL, Albers JJ 1979 Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts. J Clin Endocrinol Metab 48:887-889
17. Thompson GR, Soutar AK, Spengel FA, Jadhav A, Gavigan SJ, Myant NB 1981 Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci USA 78:2591-2595
18. Staels B, Van Tol A, Chan L, Will H, Verhoeven G, Auwerx J 1990 Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats. Endocrinology 127:1144-1152
19. Salter AM, Hayashi R, al Seeni M, Brown NF, Bruce J, Sorensen O, Atkinson EA, Middleton B, Bleackley RC, Brindley DN 1991 Effects of hypothyroidism and high-fat feeding on mRNA concentrations for the low-density-lipoprotein receptor and on acyl-CoA:cholesterol acyltransferase activities in rat liver. Biochem J 276 (Pt 3):825-832
20. Bakker O, Hudig F, Meijssen S, Wiersinga WM 1998 Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene. Biochem Biophys Res Commun 249:517-521
21. Danese MD, Ladenson PW, Meinert CL, Powe NR 2000 Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 85:2993-3001
22. Sundaram V, Hanna AN, Koneru L, Newman HA, Falko JM 1997 Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab 82:3421-3424
23. Diekman T, Demacker PN, Kastelein JJ, Stalenhoef AF, Wiersinga WM 1998 Increased oxidizability of low-density lipoproteins in hypothyroidism. J Clin Endocrinol Metab 83:1752-1755
24. de Bruin TW, van Barlingen H, Linde-Sibenius TM, van Vuurst de Vries AR, Akveld MJ, Erkelens DW 1993 Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects. J Clin Endocrinol Metab 76:121-126
25. Martinez-Triguero ML, Hernandez-Mijares A, Nguyen TT, Munoz ML, Pena H, Morillas C, Lorente D, Lluch I, Molina E 1998 Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism. Mayo Clin Proc 73:837-841
26. Becerra A, Bellido D, Luengo A, Piedrola G, De Luis DA 1999 Lipoprotein(a) and other lipoproteins in hypothyroid patients before and after thyroid replacement therapy. Clin Nutr 18:319-322
27. Tzotzas T, Krassas GE, Konstantinidis T, Bougoulia M 2000 Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid 10:803-808
28. Arem R, Escalante DA, Arem N, Morrisett JD, Patsch W 1995 Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a). Metabolism 44:1559-1563
29. Pazos F, Alvarez JJ, Rubies-Prat J, Varela C, Lasuncion MA 1995 Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins. J Clin Endocrinol Metab 80:562-566
30. Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R, Muller B 2001 TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 86:4860-4866
31. Caraccio N, Ferrannini E, Monzani F 2002 Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 87:1533-1538
32. Yildirimkaya M, Ozata M, Yilmaz K, Kilinc C, Gundogan MA, Kutluay T 1996 Lipoprotein(a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy. Endocr J 43:731-736
33. Althaus BU, Staub JJ, Ryff-De Leche A, Oberhansli A, Stahelin HB 1988 LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol (Oxf) 28:157-163
34. Caron P, Calazel C, Parra HJ, Hoff M, Louvet JP 1990 Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin Endocrinol (Oxf) 33:519-523
35. Weintraub M, Grosskopf I, Trostanesky Y, Charach G, Rubinstein A, Stern N 1999 Thyroxine replacement therapy enhances clearance of chylomicron remnants in patients with hypothyroidism. J Clin Endocrinol Metab 84:2532-2536
36. Ritter MC, Kannan CR, Bagdade JD 1996 The effects of hypothyroidism and replacement therapy on cholesteryl ester transfer. J Clin Endocrinol Metab 81:797-800
37. Tan KC, Shiu SW, Kung AW 1998 Plasma cholesteryl ester transfer protein activity in hyper- and hypothyroidism. J Clin Endocrinol Metab 83:140-143
38. Lam KS, Chan MK, Yeung RT 1986 High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction - effects of treatment. Q J Med 59:513-521
39. Packard CJ, Shepherd J, Lindsay GM, Gaw A, Taskinen MR 1993 Thyroid replacement therapy and its influence on postheparin plasma lipases and apolipoprotein-B metabolism in hypothyroidism. J Clin Endocrinol Metab 76:1209-1216
40. Saito I, Saruta T 1994 Hypertension in thyroid disorders. Endocrinol Metab Clin North Am 23:379-386
41. Fommei E, Iervasi G 2002 The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans. J Clin Endocrinol Metab 87:1996-2000
42. Luboshitzky R, Aviv A, Herer P, Lavie L 2002 Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12:421-425
43. Graettinger JS, Muenster JJ, Checchia CS, Grisson RL, Campbell JA 1958 A correlation of clinical and hemodynamic studies in patients with hypothyroidism. J Clin Invest 9:502-510
44. Obuobie K, Smith J, Evans LM, John R, Davies JS, Lazarus JH 2002 Increased central arterial stiffness in hypothyroidism. J Clin Endocrinol Metab 87:4662-4666
45. Ojamaa K, Klemperer JD, Klein I 1996 Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6:505-512
46. Mizuma H, Murakami M, Mori M 2001 Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase. Circ Res 88:313-318
47. Muller B, Zulewski H, Huber P, Ratcliffe JG, Staub JJ 1995 Impaired action of thyroid hormone associated with smoking in women with hypothyroidism. N Engl J Med 333:964-969
48. Nedrebo BG, Ericsson UB, Nygard O, Refsum H, Ueland PM, Aakvaag A, Aanderud S, Lien EA 1998 Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism 47:89-93
49. Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH 2001 Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third U.S. National Health and Nutrition Examination Survey. Atherosclerosis 155:195-200
50. Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, Muller B 2003 Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 166:379-386
51. Hussein WI, Green R, Jacobsen DW, Faiman C 1999 Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism. Ann Intern Med 131:348-351
52. Lien EA, Nedrebo BG, Varhaug JE, Nygard O, Aakvaag A, Ueland PM 2000 Plasma total homocysteine levels during short-term iatrogenic hypothyroidism. J Clin Endocrinol Metab 85:1049-1053
53. Diekman MJ, van der Put NM, Blom HJ, Tijssen JG, Wiersinga WM 2001 Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism. Clin Endocrinol (Oxf) 54:197-204
54. Barbe F, Klein M, Chango A, Fremont S, Gerard P, Weryha G, Gueant JL, Nicolas JP 2001 Homocysteine, folate, vitamin B12, and transcobalamins in patients undergoing successive hypo- and hyperthyroid states. J Clin Endocrinol Metab 86:1845-1846
55. Deicher R, Vierhapper H 2002 Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism? Thyroid 12:733-736
56. Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P, Mantzos J, Stamatelopoulos S, Koutras DA 1997 Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 7:411-414
57. Masunaga R, Nagasaka A, Nakai A, Kotake M, Sawai Y, Oda N, Mokuno T, Shimazaki K, Hayakawa N, Kato R, Hirano E, Hagiwara M, Hidaka H 1997 Alteration of platelet aggregation in patients with thyroid disorders. Metabolism 46:1128-1131
58. Hellem AJ, Segaard E, Solem JH 1975 The adhesiveness of human blood platelets and thyroid function. Acta Med Scand 197:15-17
59. Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G 2001 Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 86:732-737
60. Hanley AJ, Williams K, Stern MP, Haffner SM 2002 Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25:1177-1184
61. Shah JH, Motto GS, Papagiannes E, Williams GA 1975 Insulin metabolism in hypothyroidism. Diabetes 24:922-925
62. Bakker SJ, ter Maaten JC, Popp-Snijders C, Slaets JP, Heine RJ, Gans RO 2001 The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J Clin Endocrinol Metab 86:1206-1211
63. Blumgart H, Freedberg A, Kurland G 1955 Treatment of incapacitated euthyroid cardiac patients with radioactive iodine. Summary of results in treatment of 1,070 patients with angina pectoris or congestive failure. JAMA 157:1-4
64. Ladenson PW 1990 Recognition and management of cardiovascular disease related to thyroid dysfimction. Am J Med 88:638-641
65. Bernstein R, Muller C, Midtbo K, Smith G, Haug E, Hertzenberg L 1995 Silent myocardial ischemia in hypothyroidism. Thyroid 5:443-447
66. Bengel FM, Nekolla SG, Ibrahim T, Weniger C, Ziegler SI, Schwaiger M 2000 Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging. J Clin Endocrinol Metab 85:1822-1827
67. Levine H 1980 Compromise therapy in the patient with angina pectoris and hypothyroidism. Am J Med 69:411-418
68. Keating F, Parkin T, Selby JB, Dickinson L 1961 Treatment of heart disease associated with myxedema. Prog Cardiovasc Dis 3:364-381
69. Wren JC 1971 Symptomatic atherosclerosis: prevention or modification by treatment with desiccated thyroid. J Am Geriatr Soc 19:7-22
70. Hay I, Duick DS, Vlietstra RE, Maloney JD, Pluth JR 1981 Thyroxine therapy in hypothyroid patients undergoing coronary revascularization: A retrospective analysis. Ann Intern Med 95:456-457
71. Weinberg AD, Brennan MD, Gorman CA, Marsh HM, O'Fallon WM 1983 Outcome of anesthesia and surgery in hypothyroid patients. Arch Intern Med 143:893-897
72. Ladenson PW, Levin AA, Ridgway EC, Daniels GH 1984 Complications of surgery in hypothyroid patients. Am J Med 77:261-266
73. Drucker DJ, Burrow GN 1985 Cardiovascular surgery in the hypothyroid patient. Arch Intern Med 145:1585-1587
74. Sherman SI, Ladenson PW 1991 Percutaneous transluminal coronary angioplasty in hypothyroidism. Am J Med 90:367-370
75. Mantzoros CS, Evagelopoulou K, Moses AC 1995 Outcome of percutaneous transluminal coronary angioplasty in patients with subclinical hypothyroidism. Thyroid 5:383-387